This is the first time that the activity has breached the pre-pandemic base. The index level had declined sharply in the immediate aftermath of the national lockdown in April last year and rose steadily to be very close to the pre-pandemic levels of March 2020. However, the second wave and the ensuing localised lockdowns dented it again, till it rose after the waning of the infections.
Category:
Pandemic
Latest
Herd immunity hopes against Covid-19 Pandemic fade
The thinking was that the pandemic would ebb and then mostly fade once a chunk of the population, possibly 60% to 70%, was vaccinated or had resistance through a previous infection. But new variants like delta, which are more transmissible and been shown to evade these protections in some cases, are moving the bar for herd immunity near impossibly high levels.
Covid-19: Economic slowdown, job insecurity and fear of debt drive low confidence among people, says HDFC Life Report
Cybersecurity is top business worry in ‘age of risk’: Marsh & McLennan CEO
“CEOs like to get things done and say it’s finished,” he said. “Cyber is a never-ending phenomenon. It will continue for the rest of all of our careers.”
Climate change and the culture of remote working are the other top risks cited by companies, Glaser said. Climate is less immediate than cybersecurity because it is developing slowly and its impact, through such catastrophic events as larger wildfires and more powerful hurricanes, will increase over the next five years or more.
Medical costs of discharged COVID patients 50% above pre-admission levels:German study
The coronavirus proved especially dangerous for people with heart disease, high blood pressure or respiratory diseases, the study showed.
Where social distancing comes naturally: Finland keeps coronavirus in check
“We like to be in solitude wandering the forests and swimming in the lakes, so many Finns have actually enjoyed that they have been able to move away from the cities,” Kristian Wahlbeck, director of the Finnish Association for Mental Health (MIELI), said.
Breakthrough COVID vaccine tech could help defeat other diseases
Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines.
“Stunningly Impressive”: On Moderna Covid Vaccine Results
The vaccine is based on a relatively new technology that uses a synthetic version of a molecule called “messenger RNA” to hack into human cells, and effectively turn them into vaccine-making factories.
No vaccine based on this platform has ever been approved.
Asian stocks hit record peak as vaccine hopes dampen virus fears
“There’s just mountains of cash sitting on the sidelines, waiting to be put to work and since we’ve got this vaccine news, as well as diminished risk around the U.S. elections, all of this is flying into equities,” said Kyle Rodda, analyst at IG Markets. “Everyone’s thinking now that it’s the cue to get in.”
Scientists decode why Covid-19 spares children
According to the researchers, including those from the Vanderbilt University Medical Center (VUMC) in the US, children have lower levels of a receptor protein that the coronavirus SARS-CoV-2 needs to invade airway epithelial cells in the lung.
India’s COVID-19 caseload crosses 88-lakh mark
The number of active COVID-19 cases in the country stands at 4,79,216, which comprise 5.44 per cent of the total caseload, according to the data.
The total recoveries have surged to 82,05,728, pushing the national recovery rate to 93.09 per cent, while the fatality rate stands at 1.47 per cent.
Indian economy may be recovering faster than anticipated: Oxford Economics
Moody’s Investors Service has also revised upwards its GDP forecast for India to (-) 8.9 per cent contraction in the 2020 calendar year, as the economy reflates after a long and strict nationwide lockdown but added the recovery is patchy
Pfizer vaccine has ‘extraordinarily high degree of efficacy’: Fauci
“What I would hope is that even though there’s a degree of skepticism about vaccines in general, that when the general public sees how effective this vaccine is,” said Fauci, director of the National Institute of Allergy and Infectious Diseases, “we might see a turnaround of the attitude toward vaccination.”